Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective-Brief Report.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.

European journal of preventive cardiology·2021
Same author

Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002-2016.

Journal of clinical lipidology·2020
Same author

PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia.

Journal of clinical pharmacology·2016
Same author

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

Journal of clinical lipidology·2015
Same author

A Comparative Overview of Prescription Omega-3 Fatty Acid Products.

P & T : a peer-reviewed journal for formulary management·2015

Related Experiment Video

Updated: May 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Dyslipidemia: management using optimal lipid-lowering therapy.

Matthew K Ito1

  • 1College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, USA. itom@ohsu.edu

The Annals of Pharmacotherapy
|October 4, 2012
PubMed
Summary

Effective dyslipidemia management involves intensifying lifestyle changes and statin therapy to reach lipid goals. Statins are crucial for cardiovascular risk reduction, but careful monitoring for side effects is necessary.

Related Experiment Videos

Last Updated: May 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Dyslipidemia poses a significant risk for cardiovascular disease.
  • Current guidelines emphasize achieving specific lipid targets for cardiovascular risk reduction.

Purpose of the Study:

  • To review current dyslipidemia management strategies.
  • To explore emerging research in lipid-lowering therapies.

Main Methods:

  • Searched MEDLINE and Google for randomized controlled trials, meta-analyses, and guidelines from 2004-2012.
  • Evaluated English-language articles on large multicenter trials.

Main Results:

  • Statins are the primary treatment for patients not meeting lipid goals via lifestyle changes, demonstrating efficacy in cardiovascular disease prevention.
  • Intensive statin therapy offers greater lipid goal attainment and risk reduction.
  • Statin therapy is generally well-tolerated but carries risks of myopathy, elevated transaminases, and a low absolute risk of new-onset diabetes.

Conclusions:

  • Prioritize intensifying lifestyle changes and statin dosage for patients failing to meet LDL-C and non-HDL-C goals.
  • Consider combination therapy cautiously, as benefits remain unclear.
  • Ezetimibe is an option for statin-intolerant patients; fibrates/niacin have questionable cardiovascular benefits in statin users.